Peripheral Multiple Cytokine Profiles Identified CD39 as a Novel Biomarker for Diagnosis and Reflecting Disease Severity in Allergic Rhinitis Patients

<div>The serum levels of CD39, IL-5, and TSLP between AR patients and HCs in the validation cohort. IL: interleukin; TSLP: thymic stromal lymphopoietin; AR: allergic rhinitis; HC: healthy control.</div>

Mediators of Inflammation

fig5

Figure 5

Figure 5: Peripheral Multiple Cytokine Profiles Identified CD39 as a Novel Biomarker for Diagnosis and Reflecting Disease Severity in Allergic Rhinitis Patients 

Figure 5 | Peripheral Multiple Cytokine Profiles Identified CD39 as a Novel Biomarker for Diagnosis and Reflecting Disease Severity in Allergic Rhinitis Patients 